181 related articles for article (PubMed ID: 10228038)
1. Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis.
Kim S; Voskuhl RR
J Immunol; 1999 May; 162(9):5561-8. PubMed ID: 10228038
[TBL] [Abstract][Full Text] [Related]
2. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease.
Cua DJ; Hinton DR; Stohlman SA
J Immunol; 1995 Oct; 155(8):4052-9. PubMed ID: 7561116
[TBL] [Abstract][Full Text] [Related]
3. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
Chen Y; Inobe J; Weiner HL
J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
[TBL] [Abstract][Full Text] [Related]
4. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.
Whitacre CC; Gienapp IE; Orosz CG; Bitar DM
J Immunol; 1991 Oct; 147(7):2155-63. PubMed ID: 1717550
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
[TBL] [Abstract][Full Text] [Related]
7. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
8. Adoptively transferred experimental autoimmune encephalomyelitis in SJL/J, PL/J, and (SJL/J x PL/J)F1 mice. Influence of I-A haplotype on encephalitogenic epitope of myelin basic protein.
McCarron R; McFarlin DE
J Immunol; 1988 Aug; 141(4):1143-9. PubMed ID: 3260919
[TBL] [Abstract][Full Text] [Related]
9. Encephalitogenic and proliferative responses of Lewis rat lymphocytes distinguished by position 75- and 80-substituted peptides of myelin basic protein.
Mannie MD; Paterson PY; U'Prichard DC; Flouret G
J Immunol; 1989 Apr; 142(8):2608-16. PubMed ID: 2467932
[TBL] [Abstract][Full Text] [Related]
10. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
Ramírez F; Mason D
Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
[TBL] [Abstract][Full Text] [Related]
11. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course.
Racke MK; Burnett D; Pak SH; Albert PS; Cannella B; Raine CS; McFarlin DE; Scott DE
J Immunol; 1995 Jan; 154(1):450-8. PubMed ID: 7527821
[TBL] [Abstract][Full Text] [Related]
12. [Experimental allergic encephalomyelitis: immunopathological analysis of antigenic reactivity and loss of encephalitogenicity].
Tokuchi F
Hokkaido Igaku Zasshi; 1992 Sep; 67(5):623-37. PubMed ID: 1385288
[TBL] [Abstract][Full Text] [Related]
13. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Dalal M; Kim S; Voskuhl RR
J Immunol; 1997 Jul; 159(1):3-6. PubMed ID: 9200430
[TBL] [Abstract][Full Text] [Related]
14. Spreading of the immune response to different myelin basic protein peptides in chronic experimental autoimmune encephalomyelitis in B10.RIII mice.
Jansson L; Diener P; Engström A; Olsson T; Holmdahl R
Eur J Immunol; 1995 Aug; 25(8):2195-200. PubMed ID: 7545112
[TBL] [Abstract][Full Text] [Related]
15. Myelin protein expression is increased in lymph nodes of mice with relapsing experimental autoimmune encephalomyelitis.
MacKenzie-Graham AJ; Pribyl TM; Kim S; Porter VR; Campagnoni AT; Voskuhl RR
J Immunol; 1997 Nov; 159(9):4602-10. PubMed ID: 9379062
[TBL] [Abstract][Full Text] [Related]
16. In vivo immunomodulation by monoclonal anti-CD4 antibody. II. Effect on T cell response to myelin basic protein and experimental allergic encephalomyelitis.
Sriram S; Carroll L; Fortin S; Cooper S; Ranges G
J Immunol; 1988 Jul; 141(2):464-8. PubMed ID: 2454992
[TBL] [Abstract][Full Text] [Related]
17. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes.
Tan L; Gordon KB; Mueller JP; Matis LA; Miller SD
J Immunol; 1998 May; 160(9):4271-9. PubMed ID: 9574529
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis.
McDonald AH; Swanborg RH
J Immunol; 1988 Feb; 140(4):1132-8. PubMed ID: 2963860
[TBL] [Abstract][Full Text] [Related]
19. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity.
Willenborg DO; Staykova MA; Miyasaka M
J Immunol; 1996 Sep; 157(5):1973-80. PubMed ID: 8757317
[TBL] [Abstract][Full Text] [Related]
20. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats.
Cautain B; Damoiseaux J; Bernard I; van Straaten H; van Breda Vriesman P; Boneu B; Druet P; Saoudi A
Eur J Immunol; 2001 Apr; 31(4):1132-40. PubMed ID: 11298338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
